Cathie Wood’s ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.

Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.

Here is a quick look at all the purchases made by ARK ETFs:

FundTickerCompanyShares
ARKGADPTAdaptive Biotechnologies232,610
ARKGSRNGSoaring Eagle Acquisition4,512,926
ARKGSGFYSignify Health30,490
ARKKZZillow101,994
ARKKTSPTuSimple316,814
ARKKSRNGSoaring Eagle Acquisition2,506,461
ARKQMKFGMarkforged57,406
ARKQPATHUiPath8,178
ARKWLPSNLivePerson22,696
ARKWZZillow24,750
ARKWPATHUiPath8,641
ARKXBLDEBlade Air Mobility16,370
ARKXKTOSKratos Defense & Security Solutions49,634

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Source: Read Full Article